Mirzac D, Bange M, et al. Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson's disease. Signal Transduct Target Ther. 2025 Jan 10;10(1):10.
发布时间：2025-09-17 14:55:50 阅读次数：27
单细胞测序与药物研究
Zheng Z, Wang JB, et al. Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma. Signal Transduct Target Ther. 2025 Jan 20;10(1):29.
Luo Y, Xia Y, et al. Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors. Cell. 2024 Sep 5;187(18):4905-4925.e24.
